Inactief instrument

Andere talen Small Pharma Inc.

Aandelen

DMT

CA8316641072

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Small Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended November 30, 2023	29/01
Canadian Investment Regulatory Organization Trading Halt - DMT	23-10-23
Small Pharma Brief: Cybin Completed Acquisition of Small Pharma Inc. to Create International Clinical-stage Leader in Novel Psychedelic Therapeutics	23-10-23
Cybin Inc. completed the acquisition of Small Pharma Inc. (TSXV : DMT).	23-10-23
Small Pharma Brief: Shareholders overwhelmingly voted in favour of Cybin's acquisition	19-10-23
Small Pharma Brief: Q2 FY24 Highlights Include Cash on hand as of August 31, 2023 of approximately C$7.7 million	19-10-23
Small Pharma Reports Fiscal Second Quarter 2024 Highlights	19-10-23
Small Pharma Reports Fiscal Second Quarter 2024 Highlights	19-10-23
Tranche Update on Small Pharma Inc.'s Equity Buyback Plan announced on August 18, 2022.	19-10-23
Small Pharma Inc. Reports Earnings Results for the Second Quarter and Six Months Ended August 31, 2023	19-10-23
Cybin Inc. - Small Pharma Obtains Final Order Approving Arrangement	18-10-23
Small Pharma Announces Voting Results from Annual General and Special Meeting of Shareholders	12-10-23
Disposition of Common Shares of Small Pharma Inc.	02-10-23
Disposition of Common Shares of Small Pharma Inc.	02-10-23
Cybin Inc. - Small Pharma Reports Positive Top-line Data from SPL026 (DMT)-SSRI Drug Interaction Study in Patients with Major Depressive Disorder	28-09-23
DMT-SSRI combination shows potential for depression	27-09-23
Small Pharma Notes Positive Top-line Data from SPL026-SSRI Drug Interaction Study in Patients with Major Depressive Disorder	26-09-23
Small Pharma Brief: Reporting "Positive" Top-line Data from SPL026 (DMT)-SSRI Drug Interaction Study in Patients with Major Depressive Disorder	26-09-23
Small Pharma Reports Positive Top-line Data from SPL026 (DMT)-SSRI Drug Interaction Study in Patients with Major Depressive Disorder	26-09-23
Small Pharma Inc. Reports Positive Top-line Data from SPL026 (DMT-SSRI Drug Interaction Study in Patients with Major Depressive Disorder	26-09-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Small Pharma Inc.

Aandelen

DMT

CA8316641072

Andere talen

Filters